Aptevo Therapeutics Inc.
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Steve CohenHouse · D · TN |
APVOAptevo Therapeutics Inc. · Stock |
Sale $470.99 |
Jul 3, 2019 | Jun 24, 2019 | Filing ↗ |
Whale Activity
- Increased0
- New5
- Held5
- Decreased1
- Closed3
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 232.7K | $423K | new |
| Hudson Bay Capital Management LP | 40.7K | $74K | new |
| CITADEL ADVISORS LLC | 25.2K | $46K | new |
| GSA CAPITAL PARTNERS LLP | 21.5K | $39K | held |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.7K | $23K | held |
| VANGUARD FIDUCIARY TRUST CO | 4,142 | $8K | held |
| Tower Research Capital LLC | 1,911 | $3K | new |
| OSAIC HOLDINGS, INC. | 360 | $664 | held |
| SBI Securities Co., Ltd. | 105 | $191 | decreased |
| Caitong International Asset Management Co., Ltd | 3 | $5 | new |
| DANSKE BANK A/S | 1 | $2 | held |
| UBS Group AG | 0 | $0 | closed |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Harsanyi ZsoltDirector | Option exercise | +400 | — | — | Aug 6, 2026 | Form 4 ↗ |
| Lamothe Jeffrey G.President and CEO · Director | Option exercise | +961 | — | — | Aug 6, 2026 | Form 4 ↗ |
| Taylor DaphneSVP, CFO | Option exercise | +638 | — | — | Aug 6, 2026 | Form 4 ↗ |
| Kwon SoYoungSVP, GC, BD & Corp Affairs | Option exercise | +638 | — | — | Aug 6, 2026 | Form 4 ↗ |
| Huebner DirkSVP, CMO | Tax withholding | −156 | $4.07 | $635 | Aug 6, 2026 | Form 4 ↗ |
| Huebner DirkSVP, CMO | Option exercise | +638 | — | — | Aug 6, 2026 | Form 4 ↗ |
| Grant Grady IIIDirector | Option exercise | +400 | — | — | Aug 6, 2026 | Form 4 ↗ |
| White Marvin LExecutive Chair · Director | Tax withholding | −406 | $4.07 | $2K | Aug 6, 2026 | Form 4 ↗ |
| White Marvin LExecutive Chair · Director | Option exercise | +1,666 | — | — | Aug 6, 2026 | Form 4 ↗ |
| Abdun-Nabi DanielDirector | Option exercise | +400 | — | — | Aug 6, 2026 | Form 4 ↗ |
| Kunz Barbara LopezDirector | Option exercise | +400 | — | — | Aug 6, 2026 | Form 4 ↗ |
| Niederhuber JohnDirector | Option exercise | +400 | — | — | Aug 6, 2026 | Form 4 ↗ |
| White Marvin LExecutive Chair · Director | Option exercise | +1 | — | — | Jul 17, 2026 | Form 4 ↗ |
| Grant Grady IIIDirector | Purchase | +13.5K | $1.49 | $20K | Nov 10, 2025 | Form 4 ↗ |
| Harsanyi ZsoltDirector | Option exercise | +1 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Kunz Barbara LopezDirector | Option exercise | +1 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Abdun-Nabi DanielDirector | Option exercise | +1 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Grant Grady IIIDirector | Option exercise | +1 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Niederhuber JohnDirector | Option exercise | +1 | — | — | Jul 17, 2025 | Form 4 ↗ |
| Taylor DaphneSVP, CFO | Option exercise | +3 | — | — | Jul 17, 2025 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 12.7K | $56K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 6,351 | $15K | 0.00% | Aug 31, 2026 |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 1,548 | $4K | 0.00% | Aug 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list APVO's shares (CUSIP 03835L702), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
- Heights Capital Management, Inc.SCHEDULE 13G/A · passive (13G) · 83.9K shares4.4%
Nov 16, 2026 · ↗ - CVI Investments, Inc.SCHEDULE 13G/A · passive (13G) · 83.9K shares4.4%
Nov 16, 2026 · ↗ - Waqas KhatriSCHEDULE 13G/A · passive (13G) · 70.0K shares3.7%
Nov 12, 2026 · ↗ - Alto Opportunity Master Fund, SPC - Segregated Master Portfolio BSCHEDULE 13G/A · passive (13G) · 70.0K shares3.7%
Nov 12, 2026 · ↗ - Ayrton Capital LLCSCHEDULE 13G/A · passive (13G) · 70.0K shares3.7%
Nov 12, 2026 · ↗ - Heights Capital Management, Inc.SCHEDULE 13G/A · passive (13G) · 83.9K shares6.3%
Aug 14, 2026 · ↗ - CVI Investments, Inc.SCHEDULE 13G/A · passive (13G) · 83.9K shares6.3%
Aug 14, 2026 · ↗ - NIOWAVE, INC.SCHEDULE 13G · passive (13G) · 151.7K shares12.2%
Jun 22, 2026 · ↗ - BANK OF AMERICA CORP /DE/SCHEDULE 13G/A · passive (13G) · 86 shares0.0%
Nov 7, 2025 · ↗ - BANK OF AMERICA CORP /DE/SCHEDULE 13G · passive (13G) · 494.3K shares15.0%
Oct 6, 2025 · ↗
Corporate Lobbying
No lobbying filings found naming Aptevo Therapeutics Inc. as the client.
Government Contracts
No federal contract awards found for Aptevo Therapeutics Inc..
U.S. Patents
No USPTO patent applications found for Aptevo Therapeutics Inc..
Annual Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | $3.1M | $12.3M |
| Operating income | -$26.3M | -$24.6M | -$28.9M | -$28.6M | -$21.4M |
| Net income | -$26.0M | -$24.1M | -$17.4M | $8.0M | -$28.5M |
| Diluted EPS | -$87.27 | -$31460.23 | -$2316.83 | $1.57 | -$6.07 |
| Operating cash flow | -$25.6M | -$23.8M | -$11.7M | -$21.0M | -$21.7M |
| Cash and equivalents | $21.6M | $8.7M | $16.9M | $22.6M | $45.0M |
| Total assets | $27.2M | $15.6M | $24.8M | $34.2M | $56.6M |
| Total liabilities | $9.8M | $10.8M | $12.6M | $16.2M | $55.4M |
| Shareholders' equity | $17.4M | $4.8M | $12.2M | $18.0M | $1.2M |
As Aptevo Therapeutics Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 26, 2026 ↗
Stock Splits
- 1-for-18Reverse splitDec 30, 2025
- 1-for-20Reverse splitMay 27, 2025
- 1-for-37Reverse splitDec 4, 2024
- 1-for-44Reverse splitMar 6, 2024
- 1-for-14Reverse splitMar 27, 2020
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
- 8-K · Items 2.02, 9.01Results of operationsNov 16, 2026
EDGAR ↗ - 8-K · Items 1.01, 3.02, 8.01, 9.01Material agreement · Unregistered sale of equity · Other eventsNov 12, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsNov 9, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsNov 5, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsNov 2, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsOct 26, 2026
EDGAR ↗ - 8-K · Items 1.01, 3.03, 9.01Material agreement · Modification of rightsOct 23, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsOct 14, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsSep 24, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteSep 23, 2026
EDGAR ↗

